PROCEPT BioRobotics Corp. (PRCT)
29.10
+0.32
(+1.11%)
USD |
NASDAQ |
Jun 10, 16:00
29.10
0.00 (0.00%)
After-Hours: 18:38
PROCEPT BioRobotics Debt to Equity Ratio : 0.2243 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2243 |
| December 31, 2025 | 0.2145 |
| September 30, 2025 | 0.2075 |
| June 30, 2025 | 0.2057 |
| March 31, 2025 | 0.2051 |
| December 31, 2024 | 0.1995 |
| September 30, 2024 | 0.3343 |
| June 30, 2024 | 0.3218 |
| March 31, 2024 | 0.3082 |
| December 31, 2023 | 0.2821 |
| September 30, 2023 | 0.2664 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.518 |
| March 31, 2023 | 0.4622 |
| December 31, 2022 | 0.3923 |
| September 30, 2022 | 0.3469 |
| June 30, 2022 | 0.2241 |
| March 31, 2022 | 0.2131 |
| December 31, 2021 | 0.2026 |
| September 30, 2021 | 0.1918 |
| June 30, 2021 | 0.4461 |
| March 31, 2021 | |
| December 31, 2020 | 0.8983 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp. | 0.4264 |
| PAVmed, Inc. | 0.4304 |
| Abbott Laboratories | 0.654 |
| AngioDynamics, Inc. | 0.0657 |
| Alphatec Holdings, Inc. | 33.03 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 487.06M |
| Total Liabilities (Quarterly) | 139.40M |
| Shareholders Equity (Quarterly) | 347.67M |
| Current Ratio | 6.726 |
| Net Debt Paydown Yield | 0.03% |